Chuck Royce's CRMD Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 2.18 M shares of CorMedix Inc. (CRMD) worth $17.08 M, representing 0.14% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Chuck Royce has maintained this position in CRMD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 1.65 M shares. Largest reduction occurred in Q4 2025, reducing 199,289 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's CorMedix (CRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CorMedix (CRMD) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +288,830 | Add 15.30% | 2.18 M | $7.85 |
| Q1 2026 | +1.65 M | Add 679.90% | 1.89 M | $6.79 |
| Q4 2025 | -199,289 | Reduce 45.16% | 242,023 | $11.63 |
| Q3 2025 | +441,312 | New Buy | 441,312 | $11.63 |
Chuck Royce's CorMedix Investment FAQs
Chuck Royce first purchased CorMedix Inc. (CRMD) in Q3 2025, acquiring 441,312 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held CorMedix Inc. (CRMD) for 4 quarters since Q3 2025.
Chuck Royce's largest addition to CorMedix Inc. (CRMD) was in Q1 2026, adding 1,887,532 shares worth $12.82 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 2,176,362 shares of CorMedix Inc. (CRMD), valued at approximately $17.08 M.
As of the Q2 2026 filing, CorMedix Inc. (CRMD) represents approximately 0.14% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in CorMedix Inc. (CRMD) was 2,176,362 shares, as reported at the end of Q2 2026.